SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-002430
Filing Date
2017-04-04
Accepted
2017-04-04 16:23:27
Documents
87
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 20-F sbbp-20161231x20f.htm 20-F 3749340
2 EX-10.20 sbbp-20161231ex1020a5d7a.htm EX-10.20 121810
3 EX-10.21 sbbp-20161231ex1021f7949.htm EX-10.21 130335
4 EX-10.9 sbbp-20161231ex109423171.htm EX-10.9 145847
5 EX-12.1 sbbp-20161231ex1219985cb.htm EX-12.1 20257
6 EX-12.2 sbbp-20161231ex122f358fc.htm EX-12.2 18533
7 EX-13.1 sbbp-20161231ex1313b3b12.htm EX-13.1 15832
8 EX-21.1 sbbp-20161231ex21123ecb0.htm EX-21.1 2315
9 EX-23.1 sbbp-20161231ex231348b3c.htm EX-23.1 3976
10 EX-23.2 sbbp-20161231ex23257719e.htm EX-23.2 4452
11 GRAPHIC sbbp20161231x20f001.jpg GRAPHIC 64592
12 GRAPHIC sbbp20161231x20f002.jpg GRAPHIC 36626
13 GRAPHIC sbbp20161231x20f003.jpg GRAPHIC 15907
  Complete submission text file 0001558370-17-002430.txt   10192618

Data Files

Seq Description Document Type Size
14 EX-101.INS sbbp-20161231.xml EX-101.INS 1553045
15 EX-101.SCH sbbp-20161231.xsd EX-101.SCH 65314
16 EX-101.CAL sbbp-20161231_cal.xml EX-101.CAL 67310
17 EX-101.DEF sbbp-20161231_def.xml EX-101.DEF 243095
18 EX-101.LAB sbbp-20161231_lab.xml EX-101.LAB 592216
19 EX-101.PRE sbbp-20161231_pre.xml EX-101.PRE 454253
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 20-F | Act: 34 | File No.: 001-37569 | Film No.: 17738518
SIC: 2834 Pharmaceutical Preparations